The Disturbance of Hippocampal CaMKII/PKA/PKC Phosphorylation in Early Experimental Diabetes Mellitus

CNS Neuroscience and Therapeutics

Volumn 19, Issue 5, 2013, Pages 329-336

  Liao, Mei Hua ^a   Xiang, Ying Chun ^a,b   Huang, Ji Yun ^a   Tao, Rong Rong ^a   Tian, Yun ^a   Ye, Wei Feng ^a,c   Zhang, Gen Sheng ^a   Lu, Ying Mei ^d   Ahmed, Muhammad M ^a   Liu, Zhi Rong ^e   Fukunaga, Kohji ^f   Han, Feng ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d ZHEJIANG UNIVERSITY CITY COLLEGE   (China)

^e THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f TOHOKU UNIVERSITY   (Japan)

Author keywords

Brain; CaMKII; Diabetes; Hippocampus; Phosphorylation; PKA; PKC

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; SYNAPSIN I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIABETES MELLITUS, EXPERIMENTAL; HIPPOCAMPUS; MALE; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; STREPTOZOCIN; SYNAPSINS;

EID: 84876782618     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12084     Document Type: Article

References (32)

1. Bree Aj, Puente EC, Daphna-Iken D, Fisher SJ. Diabetes increases brain damage caused by severe hypoglycemia. Am J Physiol Endocrinol Metab 2009;297:E194-E201.
2. Anan F, Masaki T, Shimomura T, et al. Abdominal visceral fat accumulation is associated with hippocampus volume in non-dementia patients with type 2 diabetes mellitus. Neuroimage 2010;49:57-62.
3. Hershey T, Perantie DC, Wu J, Weaver PM, Black KJ, White NH. Hippocampal volumes in youth with type 1 diabetes. Diabetes 2010;59:236-241.
4. Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A. Modifiers of Cognitive function and brain structure in middle-aged and elderly individuals With type 2 diabetes mellitus. Brain Res 2009;1280:186-194.
5. Christman AL, Vannorsdall TD, Pearlson GD, Hill-Briggs F, Schretlen DJ. Canial volume, mild cognitive deficits, and functional limitations associated with Diabetes in a community sample. Arch Clin Neuropsychol 2010;25:49-59.
6. Shobe J. The role of PKA, CaMKII, and PKC in avoidance conditioning: permissive or instructive? Neurobiol Learn Mem 2002;77:291-312.
7. Moriguchi S, Han F, Shioda N, et al. Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice. J Neurochem 2009;110:170-181.
8. Li X, Han F, Liu D, Shi Y. Changes of Bax, Bcl-2 and apoptosis in hippocampus in the rat model of post-traumatic stress disorder. Neurol Res 2010;32:579-586.
9. Fukunaga K, Miyamoto E. A working model of CaM kinase II Activity in hippocampal long-term potentiation and memory. Neurosci Res 2000;38:3-17.
10. Lamsa K, Irvine EE, Giese KP, Kullmann DM. NMDA receptor-dependent long-term potentiation in mouse hippocampal interneurons shows a unique dependence on Ca (2+)/calmodulin-dependent kinases. J Physiol 2007;584(Pt 3):885-894.
11. Klann E, Chen SJ, Sweatt JD. Mechanism of protein kinase C activation during the induction and maintenance of long-term potentiation probed using a selective peptide substrate. Proc Natl Acad Sci U S A 1993;90:8337-8341.
12. Abel T, Nguyen PV, Barad M, Deuel TA, Kandel ER, Bourtchouladze R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-base long-term memory. Cell 1997;88:615-626.
13. Reed MJ, Meszaros K, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000;49:1390-1394.
14. Zhang GS, Ye WF, Tao RR, et al. Expression profiling of Ca(2+)/calmodulin-dependent signaling molecules in the rat dorsal and ventral hippocampus after acute lead exposure. Exp Toxicol Pathol 2012;64:619-624.
15. Mullasseril P, Dosemeci A, Lisman JE, Griffith LC. A structural mechanism for maintaining the 'on-state' of the CaMKII memory switch in the post-synaptic density. J Neurochem 2007;103:357-364.
16. Brocke L, Srinivasan M, Schulman H. Developmental and regional expression of multifunctional Ca2+/calmodulin-dependent protein kinase isoforms in rat brain. J Neurosci 1995;15:6797-6808.
17. Kennedy MB, Bennett MK, Erondu NE. Biochemical and immunochemical evidence that the "major postsynaptic density protein" is a subunit of a calmodulin-dependent protein kinase. Proc Natl Acad Sci U S A 1983;80:7357-7361.
18. Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, Malinow R. AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 2000;287:2262-2267.
19. Han F, Ali Raie A, Shioda N, Qin ZH, Fukunaga K. Accumulation of beta-amyloid in the brain microvessels accompanies increased hyperphosphorylated tau proteins following microsphere embolism in aged rats. Neuroscience 2008;153:414-427.
20. Roche KW, O'Brien RJ, Mammen AL, Bernhardt J, Huganir RL. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 1996;16:1179-1188.
21. Belmeguenai A, Hansel C. A role for protein phosphatases 1, 2A, and 2B in cerebellar long-term potentiation. J Neurosci 2005;25:10768-10772.
22. Yi KD, Simpkins JW. Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection. Endocrinology 2008;149:5235-5243.
23. Biessels GJ, ter Laak MP, Hamers FP, Gispen WH. Neuronal Ca2+ dysregulation in diabetes mellitus. Eur J Pharmacol 2002;447(2-3):201-209.
24. Bhardwaj SK, Kaur G. Effect of diabetes on calcium/calmodulin dependent protein kinase-II from rat brain. Neurochem Int 1999;35:329-335.
25. Fukunaga K, Muller D, Miyamoto E. Increased phosphorylation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in the induction of long-term potentiation. J Biol Chem 1995;270:6119-6124.
26. Derkach V, Barria A, Soderling TR. Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci U S A 1999;96:3269-3274.
27. Lisman J, Schulman H, Cline H. The molecular basis of CaMKII functions in synaptic and behavioural memory. Nat Rev Neurosci 2002;3:175-190.
28. Fukunaga K, Miyamoto E. Current studies on a working model of CaM kinase II in hippocampal long-term potentiation and memory. Jpn J Pharmacol 1999;79:7-15.
29. Banke TG, Bowie D, Lee H, Huganir RL, Schousboe A, Traynelis SF. Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J Neurosci 2000;20:89-102.
30. Carroll RC, Nicoll RA, Malenka RC. Effects of PKA and PKC on miniature excitatory postsynaptic currents in CA1 pyramidal cells. J Neurophysiol 1998;80:2797-2800.
31. Johannessen M, Delghandi MP, Moens U. What turns CREB on? Cell Signal 2004;16:1211-1227.
32. Colbran RJ. Protein phosphatases and calcium/calmodulin-dependent protein kinase II-dependent synaptic plasticity. J Neurosci 2004;24:8404-8409.